Arcturus Therapeutics
ARCT
#8696
Rank
C$0.27 B
Marketcap
C$9.73
Share price
1.16%
Change (1 day)
-42.45%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are C$85.14 Million. In 2024 the company made an earning of -C$0.13 Billion a decrease over its 2023 earnings that were of -C$37.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-17.69%
2024 -C$0.13 Billion240.24%
2023 -C$37.88 Million-298.78%
2022 C$19.05 M-106.79%
2021 -C$0.29 Billion181.83%
2020 -C$99.6 Million183.72%
2019 -C$35.11 Million16.93%
2018 -C$30.03 Million154.5%
2017 -C$11.8 Million-65.36%
2016 -C$34.06 Million25.93%
2015 -C$27.05 Million-41.04%
2014 -C$45.88 Million219.64%
2013 -C$14.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.02 Million-97.12% Bahamas
NRC Health
NRC
C$38.5 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA